title: [The clinical and prognostic value of inversion of the PSA/PAP ratio in prostatic cancer].
abstract: The inversion of PSA/PAP ratio is not common in patients with prostate cancer. Of 215 patients, 7 showed PSA levels below those of PAP (3.2%). All patients had metastatic disease at the time of diagnosis, 57% in multiple organs and tissues, with a Gleason value in all cases 4. Forty-three percent showed no early response to hormone therapy; mean survival interval recorded in these 7 patients was 21 months. Such a situation may suggest a poor prognosis for this neoplasia.
authors.affiliation: Servicio de Urología, Hospital General Universitario Vall d'Hebrón, Barcelona.
authors.forename: J
authors.initials: J
authors.lastname: Morote Robles
authors.forename: J A
authors.initials: JA
authors.lastname: Lorente
authors.forename: C
authors.initials: C
authors.lastname: Reig
authors.forename: M A
authors.initials: MA
authors.lastname: López Pacios
authors.forename: J A
authors.initials: JA
authors.lastname: de Torres
authors.forename: A
authors.initials: A
authors.lastname: Soler Roselló
mesh_terms: D000135:Acid Phosphatase / Q000097:blood*; D000368:Aged; D004796:Clinical Enzyme Tests; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011379:Prognosis; D011467:Prostate / Q000201:enzymology*; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000401:mortality; D016019:Survival Analysis
chemical_list: D000135:Acid Phosphatase; D017430:Prostate-Specific Antigen